Condition: Coronary Artery Disease · Sponsor: University of Athens
Olive extracts are considered to have antioxidant properties. The investigators will study the effect of olive extracts containing hydroxytyrosol (HT)-olivomed and combination of Oleuropein (OL), Hydroxytyrosol (HT), Oleocanthal (OC) - olivomedSmart on endothelial, cardiac and vascular function in patients with coronary artery disease .
This description comes directly from the study's public registry record.
Ignatios Ikonomidis · +302105832187 · ignoik@gmail.com
Konstantinos Katogiannis · +306938165687 · kenndj89@gmail.com
Always discuss trial participation with your own doctor first.
| "Attikon" University General Hospital | Athens, Attica, Greece | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04520126